Role of the JAK2/STAT pathway and losartan in human glomerular mesangial cell senescence

Molecular Medicine Reports

Volumn 3, Issue 3, 2010, Pages 393-398

  Zhou, Hongli ^a,b   Huang, Bo ^b   Du, Juan ^a   Wang, Lining ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Glomerular mesangial cells; JAK2 STAT pathway; Senescence

Indexed keywords

ANGIOTENSIN II; BETA GALACTOSIDASE; JANUS KINASE 2; LOSARTAN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT1 PROTEIN; STAT3 PROTEIN;

ARTICLE; CELL AGING; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CELL VACUOLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; GLOMERULUS; HUMAN; HUMAN CELL; MESANGIUM CELL; PHENOTYPE; PROTEIN EXPRESSION; STAINING;

EID: 77952350705     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000270     Document Type: Article

References (28)

1. Jager KJ, van Dijk PC, Dekker FW, Stengel B, Simpson K and Briggs JD: The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol 60: 352-360, 2003. (Pubitemid 37407693)
2. Kiberd BA and Clase CM: Cumulative risk for developing end-stage renal disease in the US population. J Am Soc Nephrol 13: 163-164, 2002.
3. Agodoa LY and Eggers PW: Renal replacement therapy in the United States: data from the United States renal data system. Am J Kidney Dis 25: 119-133, 1995.
4. Port FK, Fenton SSA and Mazzuchi N: Introduction. ESRD throughout the world: morbidity, mortality and quality of life. Kidney Int 57: S1-S2, 2000.
5. Mukai Y, Shimokawa H, Higashi M, Morikawa K, Matoba T, Hiroki J, Kunihiro I, Talukder HM and Takeshita A: Inhibitor renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats. Arterioscler Thromb Vasc Biol 22: 1445-1450, 2002.
6. Kansui Y, Fujii K, Goto K, Abe I and Iida M: Ang II receptor antagonist improves a related endothelial dysfunction. J Hypertens 20: 439-446, 2002. (Pubitemid 34913743)
7. Imanishi T, Kobayashi K, Kuroi A, Ikejima H and Akasaka T: Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell. Hypertens Res 3: 757-765, 2008. (Pubitemid 351772867)
8. Shan H, Bai X and Chen X: Angiotensin II induces endothelial cell senescence via the action of mitogen-activated protein kinases. Cell Biochem Funct 26: 459-466, 2008. (Pubitemid 351947698)
9. Herbert KE, Mistry Y, Hastings R, Poolman T, Niklason L and Williams B: Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and -independent pathways. Circ Res 102: 201-208, 2008. (Pubitemid 351651124)
10. Imanishi T, Hano T and Nishio I: Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 23: 97-104, 2005. (Pubitemid 40128986)
11. Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM and Fogo AB: Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int 58: 2425-2436, 2000.
12. Cruz CI, Ruiz-Torres P, del Moral RG, Rodríguez-Puyol M and Rodríguez-Puyol D: Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine. Am J Physiol. Renal Physiol 278: F122-F129, 2000.
13. Ferder L, Inserra F, Romano L, Ercole L and Pszenny V: Decreased glomerulosclerosis in aging by angiotensin converting-enzyme inhibition. J Am Soc Nephrol 5: 1147-1152, 1994. (Pubitemid 24977094)
14. Takeda K and Akira S: STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev 11: 199-207, 2000. (Pubitemid 30337459)
15. Hirano T, Ishihara K and Hibi M: Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19: 2548-2556, 2000. (Pubitemid 30339210)
16. Wang TL, Yang YH, Chang H and Huang CR: Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via JAK-STAT pathway. J Mol Cell Cardiol 37: 785-794, 2004. (Pubitemid 39194570)
17. Banes-Berceli AK, Shaw S, Ma G, Brands M, Eaton DC, Stern DM, Fulton D, Caldwell RW and Marrero MB: Effect of simvastain on high glucose and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells. Am J Physiol Renal Physiol 291: F116-F121, 2006. (Pubitemid 43945941)
18. Wang XD, Chen XM, Wang JZ, Hong Q, Feng Z, Fu B, Zhou F, Wang FY and Fan DM: Signal transducers and activators of transcription 3 mediates up-regulation of angiotensin II-induced tissue inhibitor of metalloproteinase-1 expression in cultured human senescent fibroblasts. Chin Med J 119: 1094-1102, 2006. (Pubitemid 44082880)
19. Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC and Marrero MB: Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int 61: 1605-1616, 2002. (Pubitemid 34437914)
20. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G and Schulz R: The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 120: 172-185, 2008.
21. Jung KY, Dean D, Jiang J, Gaylor S, Griffith WH, Burghardt RC and Parrish AR: Loss of N-cadherin and α-catenin in the proximal tubules of aging male Fischer 344 rats. Mech Aging Dev 125: 445-453, 2004. (Pubitemid 38746424)
22. US Renal Data System: NSRDS 2001 Annual Data System Report: Atlas of End-Stage Renal Disease in the United States. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2001.
23. Min LJ, Mogi M, Iwai M and Horiuchi M: Signaling mechanisms of angiotensin II in regulating vascular senescence. Ageing Res Rev 8: 113-121, 2009.
24. Fulop T, Larbi A, Douziech N, Levesque I, Varin A and Herbein G: Cytokine receptor signalling and aging. Mech Ageing Dev 127: 526-537, 2006.
25. Fortin CF, Larbi A, Dupuis G, Lesur O and Fülöp T Jr: GM-CSF activates the JAK/STAT pathway to rescue polymorphonuclear neutrophils from spontaneous apoptosis in young but not elderly individuals. Biogerontology 8: 173-187, 2007. (Pubitemid 46487986)
26. De Cavanagh EM, Inserra F, Ferder L and Fraga CG: Enalapril and captopril enhance glutathione dependent antioxidant defenses in mouse tissues. Am J Physiol 278: R572-R577, 2000.
27. Michel JB, Heudes D, Michel O, Poitevin P, Philippe M, Scalbert E, Corman B and Levy BI: Effect of chronic ANG I converting enzyme inhibition on aging processes. Kidney structure and function. Am J Physiol 267: R124-R135, 1994. (Pubitemid 24239196)
28. De Cavanagh EM, Piotrkowski B, Basso N, Stella I, Inserra F, Ferder L and Fraga CG: Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J 17: 1096-1098, 2003.